On September 19, Lbx Pharmacy Chain Joint Stock surged, followed by Yifeng Pharmacy Chain, Yunnan Jianzhijia Health-chain, Yixintang Pharmaceutical, and Shuyu Pingmin. Guosheng Securities' research report pointed out that the concentration of the pharmacy industry has increased and the trend of prescription drugs flowing out has not changed. With the aging population, leading pharmacy chains are expected to have stable and robust development. Looking ahead to 2024, the integration of outpatient clinics is expected to contribute significant growth, driving further increases in customer traffic and gross profit for pharmacies.
A股异动丨医药商业板块震荡反弹 老百姓涨停
Pharmaceutical commerce sector rebounds with volatility, LBX pharmacy chain hits the limit.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.